The highlights and lowlights of this morning’s sharemarket activity.
Symbion
Bateman plays his $500m card and scuttles Symbion merger
There was much drama at the extraordinary meeting of Symbion Health shareholders this morning when the mercurial Ed Bateman from Primary Healthcare sent his proxy along to tell the meeting he was going to use his 20% stake to scupper the merger with Heathscope. And that’s what he did, reports Stephen Mayne.
Big retailers may finally get a slice of the pharmaceutical pie
A significant shift, with the potential to change the nature of retail pharmacy, may be quietly unfolding, writes retail commentator Rob Lake.
